Antiplatelet Removal and HemocompatIbility EventS in the HeartMate 3 Pump
Research payments
$3,637,789
Through program year 2024, $3,637,789 in research payments was reported against Antiplatelet Removal and HemocompatIbility EventS in the HeartMate 3 Pump, across 834 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $118,228 | 58 |
| 2022 | Research | $2,067,450 | 438 |
| 2021 | Research | $1,452,112 | 338 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Vega Atlanta, GA Named on 33 payments
- Farooq Sheikh Washington, DC Named on 28 payments
- Manreet Kanwar Pittsburgh, PA Named on 25 payments
- Shelley Hall Dallas, TX Named on 19 payments
- Nasir Sulemanjee Milwaukee, WI Named on 19 payments
- Jennifer Cowger Detroit, MI Named on 19 payments
- Nir Uriel New York, NY Named on 15 payments
- Peter Eckman Palo Alto, CA Named on 15 payments
- John Ransom Little Rock, AR Named on 14 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.